A team of researchers compared the presence of short-term side effects using two image-guided radiation treatment—magnetic resonance imaging-guided daily adaptive prostate stereotactic body radiotherapy...
Hypercholesterolemia and diabetes have a minimal impact on major adverse cardiovascular events (MACE) risk in patients with prostate cancer (PCa) who are treated with androgen deprivation therapy (ADT),...
The researchers set out to determine whether neoadjuvant novel hormonal agent (NHA) therapy before radical prostatectomy can improve outcomes in men with high-risk prostate cancer.
Study findings presented at the 2022 ASCO Annual Meeting reveal oncologists’ and urologists’ reasons for underutilization of treatment intensification for patients with metastatic castration–sensitive...
Previous studies have sought to determine the relationship between cancer and a vegetarian diet. In this study, the researchers examined the impact of various vegetarian and non-vegetarian diets on the risk...
A recent study comparing radiotherapy methods for prostate cancer suggests that physician-reported toxicities may be lower for patients treated with high-dose-rate brachytherapy, and patient-reported...
To assess the potential role of urine pH in predicting prostate cancer, researchers compared urine pH levels in patients with prostate cancer and patients with benign prostatic hyperplasia.
Dr Shilajit Kundu and colleagues evaluated data on more than 10,000 men to determine how prostate cancer affects men with and without inflammatory bowel disease.
In a new statement, the United States Preventive Services Task Force has updated its 2012 recommendations on prostate-specific antigen-based screening for prostate cancer.
